SBIA
Sheaff Brock Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $290K | Buy |
2,619
+120
| +5% | +$13.3K | 0.03% | 337 |
|
|
2024
Q4 | $341K | Buy |
2,499
+261
| +12% | +$35.6K | 0.03% | 310 |
|
|
2024
Q3 | $258K | Buy |
2,238
+268
| +14% | +$30.9K | 0.02% | 351 |
|
|
2024
Q2 | $271K | Buy |
1,970
+92
| +5% | +$12.7K | 0.03% | 337 |
|
|
2024
Q1 | $259K | Buy |
1,878
+197
| +12% | +$27.2K | 0.02% | 374 |
|
|
2023
Q4 | $221K | Buy |
+1,681
| New | +$221K | 0.02% | 396 |
|
|
2023
Q1 | – | Sell |
-1,721
| Closed | -$206K | – | 509 |
|
|
2022
Q4 | $206K | Buy |
+1,721
| New | +$206K | 0.02% | 402 |
|